Resveratrol preconditioning induces cellular stress proteins and is mediated via NMDA and estrogen receptors

Neuroscience

Volumn 166, Issue 2, 2010, Pages 445-454

  Saleh, M C ^a   Connell, B J ^a   Saleh, T M ^a  

^a UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

Author keywords

Endoplasmic reticulum; Ischemia; Middle cerebral artery occlusion; Renal sympathetic nerve activity

Indexed keywords

ANTIESTROGEN; CALPAIN 2; CHAPERONE; CYSTEINE PROTEINASE; ESTROGEN RECEPTOR; GLUCOSE REGULATED PROTEIN 78; GLUCOSE REGULATED PROTEIN 94; HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 70; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; RESVERATROL; ANTIOXIDANT; GLUCOSE REGULATED PROTEINS; GLUCOSE-REGULATED PROTEINS; MEMBRANE PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPROTECTIVE AGENT; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CELL STRESS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; ENDOPLASMIC RETICULUM STRESS; IN VIVO STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NERVE CONDUCTION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; RAT; RECEPTOR BLOCKING; SYMPATHETIC NERVE; TREATMENT RESPONSE; ADRENERGIC SYSTEM; ANALYSIS OF VARIANCE; ANIMAL; BLOOD PRESSURE; BRAIN; CEREBRAL ARTERY DISEASE; DRUG EFFECT; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; TIME; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; BLOTTING, WESTERN; BRAIN; HEAT-SHOCK PROTEINS; HSP70 HEAT-SHOCK PROTEINS; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MEMBRANE PROTEINS; MOLECULAR CHAPERONES; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ESTROGEN; RECEPTORS, N-METHYL-D-ASPARTATE; STILBENES; SYMPATHETIC NERVOUS SYSTEM; TIME FACTORS;

EID: 77951895853     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2009.12.060     Document Type: Article

References (49)

1. Ahn J, Piri N, Caprioli J, Munemasa Y, Kim SH, Kwong JM (2008) Expression of heat shock transcription factors and heat shock protein 72 in rat retina after intravitreal injection of low dose Nmethyl-D-aspartate. Neurosci Lett 433:11-16.
2. Andrabi SA, Spina MG, Lorenz P, Ebmeyer U, Wolf G, Horn TFW (2004) Oxyresveratrol (trans-2,3=, 4,5=-tetrahydroxystilbene) is neuroprotective and inhibits the apoptotic cell death in transient cerebral ischemia. Brain Res 1017:98-107.
3. Athar M, Back JH, Kopelovich L, Bickers DR, Al K (2009) Multiple molecular targets of resveratrol: anti-carcinogenic mechanisms. Arch Biochem Biophys 486:95-102.
4. Basley JP, Marre-Fournier F, Le BJC, Habrioux G, Chulia AJ (2000) Estrogenic/antiestrogenic and scavenging properties of (E)-and (Z)-resveratrol. Life Sci 66:769-777.
5. Bowers JL, Tyulmenkov VV, Jernigan SC, Klinge CM (2000) Resveratrol acts as a mixed agonist/antagonist for estrogen receptors α and β. Endocrinology 141:3657-3667.
6. Breuer C, Wolf G, Andrabi SA, Lorenz P, Horn TFW (2006) Blood- brain barrier permeability to the neuroprotectant oxyresveratrol. Neurosci Lett 393:113-118.
7. Candelario-Jalil E, de Oliveira AC, Graf S, Bhatia HS, Hull M, Munoz E, Fiebich BL (2007) Resveratrol potently reduces prostaglandin E2 production and free radical formation in lipopolysaccharideactivated primary rat microglia. J Neuroinflammation 4:25.
8. Chander V, Chopra K (2005) Role of nitric oxide in resveratrol-induced renal protective effects of ischemic preconditioning. J Vasc Surg 42:1198-1205.
9. Chang Y, Wang SJ (2009) Inhibitory effect of glutamate release from rat cerebrocortical nerve terminals by resveratrol. Neurochem Int 54:135-141.
10. Chinta SJ, Poksay KS, Kaundinya G, Hart M, Bredesen DE, Andersen JK, Rao RV (2009) Endoplasmic reticulum stress-induced cell death in dopaminergic cells: effect of resveratrol. J Mol Neurosci 39:157-168.
11. Choi DW (1988) Glutamate toxicity and diseases of the nervous system. Neuron 1:623-634.
12. Choi DW (1992) Excitotoxic cell death. J Neurobiol 23:1261-1276.
13. Connell BJ, Crosby KM, Richard MJP, Mayne MB, Saleh TM (2007) Estrogen-mediated neuroprotection in the cortex may require NMDA receptor activation. Neuroscience 146:160-169.
14. Dirnagl U, Becker K, Meisel A (2009) Preconditioning and tolerance against cerebral ischemia. Lancet Neurol 8:398-412.
15. Gao ZB, Chen XQ, Hu GY (2006) Inhibition of excitatory synaptic transmission by trans-resveratrol in rat hippocampus. Brain Res 1111:41-47.
16. Gaspary H, Graham SH, Sagar SM, Sharp FR (1995) HSP70 heat shock protein induction following global ischemia in the rat. Brain Res Mol Brain Res 34:327-332.
17. Gehm BD, McAndrews JM, Chien PY, Jameson JL (1997) Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor. Proc Natl Acad Sci U S A 94:14138-14143.
18. Hattori R, Otani H, Maulik N, Das DK (2002) Pharmacological preconditioning with resveratrol: role of nitric oxide. Am J Physiol 282: H1988-H1995.
19. Hayashi T, Saito A, Okuno S, Ferrand-Drake M, Chan PH (2003) Induction of GRP78 by ischemic preconditioning reduces endoplasmic reticulum stress and prevents delayed neuronal cell death. J Cereb Blood Flow Metab 23:949-961.
20. Hong SC (1994) Neuroprotection with a calpain inhibitor in a model of focal cerebral ischemia. Stroke 25:663-669.
21. Huang SS, Tsai MC, Chih CL, Hung LM, Tsai SK (2001) Resveratrol reduction of infarct size in Long-Evans rats subjected to focal cerebral ischemia. Life Sci 69:1057-1065.
22. Hung LM, Su MJ, Chen JK (2004) Resveratrol protects myocardial ischemia-reperfusion injury through both NO-dependent and NOindependent mechanisms. Free Radic Biol Med 36:774-781.
23. Kang OH, Jang HJ, Chae HS, Oh YC, Choi JG, Lee YS, Kim JH, Kim YC, Sohn DH, Park H, Kwon DY (2009) Anti-inflammatory mechanisms of resveratrol in activated HMC-1 cells: pivotal roles of NF-kappaB and MAPK. Pharmacol Res 59:330-337.
24. Kiziltepe U, Turan NN, Han U, Ulus AT, Akar F (2004) Resveratrol, a red wine polyphenol, protects spinal cord from ischemia-reperfusion injury. J Vasc Surg 40:138-145.
25. Lee AS (2001) The glucose-regulated proteins: stress induction and clinical applications. Trends Biochem Sci 26:504-510.
26. Lehotsky J, Urban P, Pavlikova M, Tatarkova Z, Kaminska B, Kaplan P (2009) Molecular mechanisms leading to neuroprotection/ischemic tolerance: effect of preconditioning on the stress reaction of endoplasmic reticulum. Cell Mol Neurobiol 29:917-925.
27. Lin CH, Chen PS, Gean PW (2008) Glutamate preconditioning prevents neuronal death induced by combined oxygen-glucose deprivation in cultured cortical neurons. Eur J Pharmacol 589:85-93.
28. Ma HJ, Cao YK, Liu YX, Wang R, Wu YM (2008) Microinjection of resveratrol into rostral ventrolateral medulla decreases sympathetic vasomotor tone through nitric oxide and intracellular Ca2+ in anesthetized male rats. Acta Pharmacol Sin 29:906-912.
29. Oida Y, Shimazawa M, Imaizumi K, Hara H (2008a) Involvement of endoplasmic reticulum stress in the neuronal death induced by transient forebrain ischemia in gerbil. Neuroscience 151:111-119.
30. Oida Y, Izuta H, Oyagi A, Shimazawa M, Kudo T, Imaizumi K, Hara H (2008b) Induction of BiP, an ER-resident protein, prevents the neuronal death induced by transient forebrain ischemia in gerbil. Brain Res 1208:217-224.
31. Oppenheimer S (2006) Cerebrogenic cardiac arrhythmias: cortical lateralization and clinical significance. Clin Auton Res 16:6-11.
32. Park JW, Woo KJ, Lee JT, Lim JH, Lee TJ, Kim SH, Choi YH, Kwon TK (2007) Resveratrol induces pro-apoptotic endoplasmic reticulum stress in human colon cancer cells. Oncol Rep 18:1269-1273.
33. Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates. New York: Academic Press.
34. Raval AP, Dave KR, Perez-Pinzon MA (2006a) Resveratrol mimics ischemic preconditioning in the brain. J Cereb Blood Flow Metab 26:1141-1147.
35. Raval AP, Bramlett H, Perez-Pinzon MA (2006b) Estrogen preconditioning protects the hippocampal CA1 against ischemia. Neuroscience 141:1721-1730.
36. Raval AP, Lin HW, Dave KR, DeFazio A, Della Morte D, Kim EJ, Perez-Pinzon MA (2008) Resveratrol and ischemic preconditioning in the brain. Curr Med Chem 15:1545-1551.
37. Saleh MC, Connell BJ, Saleh TM (2009a) Estrogen may contribute to ischemic tolerance through modulation of cellular stress-related proteins. Neurosci Res 63:273-279.
38. Saleh MC, Connell BJ, Saleh TM (2009b) Ischemic tolerance following low dose NMDA involves modulation of cellular stress proteins. Brain Res 1247:212-220.
39. Saleh TM, Connell BJ, Saleh MC (2000) Acute injection of 17β-estradiol enhances cardiovascular reflexes and autonomic tone in ovariectomized female rats. Auton Neurosci 84:78-88.
40. Saleh TM, Cribb AE, Connell BJ (2001) Estrogen-induced recovery of autonomic function after middle cerebral artery occlusion in male rats. Am J Physiol 281:R1531-R1539.
41. Saleh TM, Connell BJ, Cribb AE (2005) Estrogen in the parabrachial nucleus attenuates the sympathoexcitation following MCAO in male rats. Brain Res 1066:187-195.
42. Sareen D, Darjatmoko SR, Albert DM, Polans AS (2007) Mitochondria, calcium, and calpain are key mediators of resveratrol-induced apoptosis in breast cancer. Mol Pharmacol 72:1466-1475.
43. Siman R (1988) Excitatory amino acids activate calpain I and induce structural protein breakdown in vivo. Neuron 1:279-287.
44. Siman R, Bozyczko-Coyne D, Savage MJ, Roberts-Lewis JM (1996) The calcium-activated protease calpain I and ischemia-induced neurodegeneration. Adv Neurol 71:167-174.
45. Sun W, Wang W, Kim J, Keng P, Yang S, Zhang H, Liu C, Okunieff P, Zhang L (2008) Anti-cancer effect of resveratrol is associated with induction of apoptosis via a mitochondrial pathway alignment. Adv Exp Med Biol 614:179-186.
46. Tauskela JS, Comas T, Hewitt K, Monette R, Paris J, Hogan M, Morley P (2001) Cross-tolerance to otherwise lethal N-methyl-D-aspartate and oxygen-glucose deprivation in preconditioned cortical cultures. Neuroscience 107:571-584.
47. Tsai SK, Hung LM, Fu YT, Cheng H, Nien MW, Liu HY, Zhang F, Huang SS (2007) Resveratrol neuroprotective effects during focal cerebral ischemia injury via nitric oxide mechanism in rats. J Vasc Surg 46:346-353.
48. Vosler PS, Brennan CS, Chen J (2008) Calpain-mediated signaling mechanisms in neuronal injury and neurodegeneration. Mol Neurobiol 38:78-100.
49. Witte OW, Bidmon HJ, Schiene K, Redecker C, Hagemann G (2000) Functional differentiation of multiple perilesional zones after focal cerebral ischemia. J Cereb Blood Flow Metab 20:1149-1165.